December 2, 2025 02:42 PM EST FDA+ FDA to re­move some mon­key test­ing from mon­o­clon­al an­ti­body de­vel­op­ment Zachary Brennan Senior Editor The FDA on Tues­day un­veiled new rec­om­men­da­tions on how bio­phar­ma com­pa­nies can in some cas­es re­duce or elim­i­nate test­ing mon­o­clon­al an­ti­bod­ies (mAbs) in mon­keys be­fore … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER ENDPOINTS CAREERS Client Engagement Mgr - Life Sciences Strategy & Intelligence Sedulo Group Remote VIEW JOB OFFER post your job now